These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15051626)

  • 1. Peripheral kappa-opioid agonists for visceral pain.
    Rivière PJ
    Br J Pharmacol; 2004 Apr; 141(8):1331-4. PubMed ID: 15051626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delta and kappa opioid receptors as suitable drug targets for pain.
    Vanderah TW
    Clin J Pain; 2010 Jan; 26 Suppl 10():S10-5. PubMed ID: 20026960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FE200041 (D-Phe-D-Phe-D-Nle-D-Arg-NH2): A peripheral efficacious kappa opioid agonist with unprecedented selectivity.
    Vanderah TW; Schteingart CD; Trojnar J; Junien JL; Lai J; Riviere PJ
    J Pharmacol Exp Ther; 2004 Jul; 310(1):326-33. PubMed ID: 14993260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analgesic efficacy of peripheral kappa-opioid receptor agonist CR665 compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective effect on visceral pain.
    Arendt-Nielsen L; Olesen AE; Staahl C; Menzaghi F; Kell S; Wong GY; Drewes AM
    Anesthesiology; 2009 Sep; 111(3):616-24. PubMed ID: 19672186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical function-based pharmacophore development for novel, selective kappa opioid receptor agonists.
    Singh N; Nolan TL; McCurdy CR
    J Mol Graph Model; 2008 Sep; 27(2):131-9. PubMed ID: 18456526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of kappa-opioid receptors in visceral nociception in mice.
    Larsson MH; Bayati A; Lindström E; Larsson H
    Neurogastroenterol Motil; 2008 Oct; 20(10):1157-64. PubMed ID: 18643891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.
    Gallantine EL; Meert TF
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing pain in chronic pancreatitis:therapeutic value of opioid treatment.
    Eisenberg E; Ståhl C; Drewes AM; Arendt-Nielsen L
    J Pain Palliat Care Pharmacother; 2007; 21(3):63-5. PubMed ID: 18032359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of kappa-opioid receptor agonists on tetrodotoxin-resistant sodium channels in primary sensory neurons.
    Su X; Castle NA; Antonio B; Roeloffs R; Thomas JB; Krafte DS; Chapman ML
    Anesth Analg; 2009 Aug; 109(2):632-40. PubMed ID: 19608841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging therapeutic roles of κ-opioid agonists.
    Jones MR; Kaye AD; Kaye AJ; Urman RD
    J Opioid Manag; 2016; 12(2):101-7. PubMed ID: 27194194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central and peripheral analgesic agents: chemical strategies for limiting brain penetration in kappa-opioid agonists belonging to different chemical classes.
    Giardina G; Clarke GD; Grugni M; Sbacchi M; Vecchietti V
    Farmaco; 1995 Jun; 50(6):405-18. PubMed ID: 7669179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of novel peripherally restricted kappa-opioid receptor agonists.
    Kumar V; Guo D; Cassel JA; Daubert JD; Dehaven RN; Dehaven-Hudkins DL; Gauntner EK; Gottshall SL; Greiner SL; Koblish M; Little PJ; Mansson E; Maycock AL
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1091-5. PubMed ID: 15686919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agents.
    Akbar A; Walters JR; Ghosh S
    Aliment Pharmacol Ther; 2009 Sep; 30(5):423-35. PubMed ID: 19493256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analgesia from a peripherally active kappa-opioid receptor agonist in patients with chronic pancreatitis.
    Eisenach JC; Carpenter R; Curry R
    Pain; 2003 Jan; 101(1-2):89-95. PubMed ID: 12507703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?
    Albert-Vartanian A; Boyd MR; Hall AL; Morgado SJ; Nguyen E; Nguyen VP; Patel SP; Russo LJ; Shao AJ; Raffa RB
    J Clin Pharm Ther; 2016 Aug; 41(4):371-82. PubMed ID: 27245498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of kappa opioid receptor agonists on attention as assessed by a 5-choice serial reaction time task in rats.
    Shannon HE; Eberle EL; Mitch CH; McKinzie DL; Statnick MA
    Neuropharmacology; 2007 Dec; 53(8):930-41. PubMed ID: 17959202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in opioid analgesia: clinical and experimental findings.
    Fillingim RB; Gear RW
    Eur J Pain; 2004 Oct; 8(5):413-25. PubMed ID: 15324773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kappa opioids and the modulation of pain.
    Kivell B; Prisinzano TE
    Psychopharmacology (Berl); 2010 Jun; 210(2):109-19. PubMed ID: 20372880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.